High expression of CCL20 not only promotes the appearance of EMT in HCC cells, but also activates STAT3 to induce Th9 helper T cells with tumor‐promoting effects targeting the HCC tumor microenvironment [33]. The gene discussed is CCL20; the disease is hepatocellular carcinoma.